Welltower Announces Date of Third Quarter 2019 Earnings Release, Conference Call and Webcast
TOLEDO, Ohio, Oct. 4, 2019 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) today announced that it will release its third quarter 2019 financial results after the close of trading on the New York Stock Exchange on Monday, October 28, 2019. The Company will host a conference call and webcast on Tuesday, October 29, 2019 at 9:00 a.m. Eastern Time to discuss these results. The Company's earnings release will be available in the Investors section of the Company's website.
Investors and other interested parties may access the conference call in the following ways:
At the Company's website: www.welltower.com. To participate in the webcast, please log on 15 minutes in advance of the scheduled call to download the necessary software. A webcast replay will be available approximately two hours after the conclusion of the conference call and will be available for 90 days.
By telephone: The United States dial-in number is (888) 346-2469. The international dial-in number is (706) 758-4923. The conference ID number is 9352239.
A replay of the conference call will be available beginning at approximately 1:00 p.m. on October 29, 2019 and ending on November 12, 2019. The replay dial-in number for U.S. participants is (855) 859-2056. For international participants, the replay dial-in number is (404) 537-3406. The replay conference ID number is 9352239.
About Welltower
Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltowertm, a real estate investment trust (REIT), owns interests in properties concentrated in major, high growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing, post-acute communities and outpatient medical properties. For more information, visit www.welltower.com.
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of...
According to the Corporate Whistleblower Center, "We have by far the most robust initiative in the nation related to extremely short-staffed long-term care facilities billing Medicare-Medicaid as if they were fully staffed. In August of 2023 we...
Navamedic ASA (OSE: Nava) will be presenting its 1st quarter 2024 results on Tuesday, April 30, 2024. The presentation will be held at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. A link to the webcast and the presentation will...
Response Pharmaceuticals, Inc., a clinical stage company focused on weight management and metabolic health in high-risk populations, today announced positive topline results from its Phase 1b clinical trial evaluating the safety and efficacy of...
Dr. Mary C. McCluskey, psychotherapist, and author revitalizes Dr. Alfred Adler, the "Pioneer in the Prevention of Mental Health Disorders" and Dr. Pierre Janet "Father of Trauma Treatment Theory" using a time-traveling hot air balloon to create a...
The "Peptide Synthesis: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of...